The DOI matches its Crossref record; 111 of the 111 references it cites were found in a registry or an index.
Candidate drugs against SARS-CoV-2 and COVID-19
Open accessAbstract
Graphical abstract Coronavirus SARS-CoV-2 enters host cells via ligation of its spike protein (S glycoprotein) with host cell ACE2 receptor that is primed by TMPRSS2 protease. ACE2- and TMPRSS2-mediated cell entry can be blocked by experimental and established drugs. Virus replication and assembly can be inhibited by antiviral drugs targeting viral RNA-dependent RNA polymerase (RdRp) and main protease (3Clpro).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Gautret, P., Lagier, J.-C., Parola, P., Hoang, V. T., Meddeb, L., Mailhe, M., Doudier, B., Courjon, J., Giordanengo, V., Vieira, V. E., et al. (2020) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2020.105949 · Cited by 5,288
RetractedA novel coronavirus from patients with pneumonia in China, 2019
Zhu, N., Zhang, D., Wang, W., Li, X., Yang, B., Song, J., Zhao, X., Huang, B., Shi, W., Lu, R., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001017 · Cited by 28,244
Hoffmann, M., Kleine-Weber, H., Schroeder, S., Krüger, N., Herrler, T., Erichsen, S., Schiergens, T. S., Herrler, G., Wu, N.-H., Nitsche, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.02.052 · Cited by 20,286
Lu, R., Zhao, X., Li, J., Niu, P., Yang, B., Wu, H., Wang, W., Song, H., Huang, B., Zhu, N., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30251-8 · Cited by 11,907
Structure, function and antigenicity of the SARS-CoV-2 spike glycoprotein
Walls, A. C., Park, Y.-J., Tortorici, M. A., Wall, A., McGuire, A. T., & Veesler, D. (2020) · doi:10.1101/2020.02.19.956581 · Cited by 8,586
Wang, M., Cao, R., Zhang, L., Yang, X., Liu, J., Xu, M., Shi, Z., Hu, Z., Zhong, W., & Xiao, G. (2020) · Cell Research · doi:10.1038/s41422-020-0282-0 · Cited by 6,958
Virological assessment of hospitalized patients with COVID-2019
Wölfel, R., Corman, V. M., Guggemos, W., Seilmaier, M., Zange, S., Müller, M. A., Niemeyer, D., Jones, T. C., Vollmar, P., Rothe, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2196-x · Cited by 6,661
Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus
Li, W., Moore, M. J., Vasilieva, N., Sui, J., Wong, S. K., Berne, M. A., Somasundaran, M., Sullivan, J. L., Luzuriaga, K., Greenough, T. C., et al. (2003) · Nature · doi:10.1038/nature02145 · Cited by 5,923
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
Cao, B., Wang, Y., Wen, D., Liu, W., Wang, J., Fan, G., Ruan, L., Song, B., Cai, Y., Wei, M., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2001282 · Cited by 5,187
Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
Jin, Z., Du, X., Xu, Y., Deng, Y., Liu, M., Zhao, Y., Zhang, B., Li, X., Zhang, L., Peng, C., et al. (2020) · Nature · doi:10.1038/s41586-020-2223-y · Cited by 4,358
Epidemiology, Genetic Recombination, and Pathogenesis of Coronaviruses
Su, S., Wong, G., Shi, W., Liu, J., Lai, A. C. K., Zhou, J., Liu, W., Bi, Y., & Gao, G. F. (2016) · Trends in Microbiology · doi:10.1016/j.tim.2016.03.003 · Cited by 2,948
Zhang, L., Lin, D., Sun, X., Curth, U., Drosten, C., Sauerhering, L., Becker, S., Rox, K., & Hilgenfeld, R. (2020) · Science · doi:10.1126/science.abb3405 · Cited by 2,895
Compassionate Use of Remdesivir for Patients with Severe Covid-19
Grein, J., Ohmagari, N., Shin, D., Diaz, G., Asperges, E., Castagna, A., Feldt, T., Green, G., Green, M. L., Lescure, F.-X., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2007016 · Cited by 2,737
Yao, X., Ye, F., Zhang, M., Cui, C., Huang, B., Niu, P., Liu, X., Zhao, L., Dong, E., Song, C., et al. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa237 · Cited by 2,662
Gao, J., Tian, Z., & Yang, X. (2020) · BioScience Trends · doi:10.5582/bst.2020.01047 · Cited by 2,590
Monteil, V., Kwon, H., Prado, P., Hagelkrüys, A., Wimmer, R. A., Stahl, M., Leopoldi, A., Garreta, E., Hurtado del Pozo, C., Prosper, F., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.004 · Cited by 2,122
Chloroquine is a potent inhibitor of SARS coronavirus infection and spread
Vincent, M. J., Bergeron, E., Benjannet, S., Erickson, B. R., Rollin, P. E., Ksiazek, T. G., Seidah, N. G., & Nichol, S. T. (2005) · Virology Journal · doi:10.1186/1743-422x-2-69 · Cited by 1,811
Isolation and characterization of a bat SARS-like coronavirus that uses the ACE2 receptor
Ge, X.-Y., Li, J.-L., Yang, X.-L., Chmura, A. A., Zhu, G., Epstein, J. H., Mazet, J. K., Hu, B., Zhang, W., Peng, C., et al. (2013) · Nature · doi:10.1038/nature12711 · Cited by 1,778
The outbreak of COVID-19: An overview
Wu, Y.-C., Chen, C.-S., & Chan, Y.-J. (2020) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000000270 · Cited by 1,768
Sheahan, T. P., Sims, A. C., Leist, S. R., Schäfer, A., Won, J., Brown, A. J., Montgomery, S. A., Hogg, A., Babusis, D., Clarke, M. O., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13940-6 · Cited by 1,738
Coronavirus Main Proteinase (3CL pro ) Structure: Basis for Design of Anti-SARS Drugs
Anand, K., Ziebuhr, J., Wadhwani, P., Mesters, J. R., & Hilgenfeld, R. (2003) · Science · doi:10.1126/science.1085658 · Cited by 1,728
Role of lopinavir/ritonavir in the treatment of SARS: initial virological and clinical findings
Chu, C. M. (2004) · Thorax · doi:10.1136/thorax.2003.012658 · Cited by 1,645
A Randomized, Controlled Trial of Ebola Virus Disease Therapeutics
Mulangu, S., Dodd, L. E., Davey, R. T., Tshiani Mbaya, O., Proschan, M., Mukadi, D., Lusakibanza Manzo, M., Nzolo, D., Tshomba Oloma, A., Ibanda, A., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1910993 · Cited by 1,605
Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses
Sheahan, T. P., Sims, A. C., Graham, R. L., Menachery, V. D., Gralinski, L. E., Case, J. B., Leist, S. R., Pyrc, K., Feng, J. Y., Trantcheva, I., et al. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aal3653 · Cited by 1,571
Therapeutic efficacy of the small molecule GS-5734 against Ebola virus in rhesus monkeys
Warren, T. K., Jordan, R., Lo, M. K., Ray, A. S., Mackman, R. L., Soloveva, V., Siegel, D., Perron, M., Bannister, R., Hui, H. C., et al. (2016) · Nature · doi:10.1038/nature17180 · Cited by 1,556
Agostini, M. L., Andres, E. L., Sims, A. C., Graham, R. L., Sheahan, T. P., Lu, X., Smith, E. C., Case, J. B., Feng, J. Y., Jordan, R., et al. (2018) · mBio · doi:10.1128/mbio.00221-18 · Cited by 1,416
A systematic review on the efficacy and safety of chloroquine for the treatment of COVID-19
Cortegiani, A., Ingoglia, G., Ippolito, M., Giarratano, A., & Einav, S. (2020) · Journal of Critical Care · doi:10.1016/j.jcrc.2020.03.005 · Cited by 1,160
Glowacka, I., Bertram, S., Müller, M. A., Allen, P., Soilleux, E., Pfefferle, S., Steffen, I., Tsegaye, T. S., He, Y., Gnirss, K., et al. (2011) · Journal of Virology · doi:10.1128/jvi.02232-10 · Cited by 1,108
Sheahan, T. P., Sims, A. C., Zhou, S., Graham, R. L., Pruijssers, A. J., Agostini, M. L., Leist, S. R., Schäfer, A., Dinnon, K. H., Stevens, L. J., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abb5883 · Cited by 1,071
Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
FURUTA, Y., KOMENO, T., & NAKAMURA, T. (2017) · Proceedings of the Japan Academy, Series B · doi:10.2183/pjab.93.027 · Cited by 1,070
Clinical Features of 69 Cases With Coronavirus Disease 2019 in Wuhan, China
Wang, Z., Yang, B., Li, Q., Wen, L., & Zhang, R. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa272 · Cited by 1,063
de Wit, E., Feldmann, F., Cronin, J., Jordan, R., Okumura, A., Thomas, T., Scott, D., Cihlar, T., & Feldmann, H. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1922083117 · Cited by 887
Báez-Santos, Y. M., St. John, S. E., & Mesecar, A. D. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2014.12.015 · Cited by 854
Gordon, C. J., Tchesnokov, E. P., Feng, J. Y., Porter, D. P., & Götte, M. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ac120.013056 · Cited by 850
Efficacy of hydroxychloroquine in patients with COVID-19: results of a randomized clinical trial
Chen, Z., Hu, J., Zhang, Z., Jiang, S., Han, S., Yan, D., Zhuang, R., Hu, B., & Zhang, Z. (2020) · medRxiv · doi:10.1101/2020.03.22.20040758 · Cited by 847
Song, W., Gui, M., Wang, X., & Xiang, Y. (2018) · PLOS Pathogens · doi:10.1371/journal.ppat.1007236 · Cited by 834
Matsuyama, S., Nagata, N., Shirato, K., Kawase, M., Takeda, M., & Taguchi, F. (2010) · Journal of Virology · doi:10.1128/jvi.01542-10 · Cited by 778
Morse, J. S., Lalonde, T., Xu, S., & Liu, W. R. (2020) · ChemBioChem · doi:10.1002/cbic.202000047 · Cited by 776
Structural insights into coronavirus entry
(2019) · Advances in Virus Research · doi:10.1016/bs.aivir.2019.08.002 · Cited by 769
An updated estimation of the risk of transmission of the novel coronavirus (2019-nCov)
Tang, B., Bragazzi, N. L., Li, Q., Tang, S., Xiao, Y., & Wu, J. (2020) · Infectious Disease Modelling · doi:10.1016/j.idm.2020.02.001 · Cited by 756
Shulla, A., Heald-Sargent, T., Subramanya, G., Zhao, J., Perlman, S., & Gallagher, T. (2011) · Journal of Virology · doi:10.1128/jvi.02062-10 · Cited by 693
In vitro inhibition of severe acute respiratory syndrome coronavirus by chloroquine
Keyaerts, E., Vijgen, L., Maes, P., Neyts, J., & Ranst, M. V. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.08.085 · Cited by 649
Role of Nicotianamine in the Intracellular Delivery of Metals and Plant Reproductive Development
Takahashi, M., Terada, Y., Nakai, I., Nakanishi, H., Yoshimura, E., Mori, S., & Nishizawa, N. K. (2003) · The Plant Cell · doi:10.1105/tpc.010256 · Cited by 636
Mechanism of Inhibition of Ebola Virus RNA-Dependent RNA Polymerase by Remdesivir
Tchesnokov, E. P., Feng, J. Y., Porter, D. P., & Götte, M. (2019) · Viruses · doi:10.3390/v11040326 · Cited by 622
Hydroxychloroquine: From Malaria to Autoimmunity
Ben-Zvi, I., Kivity, S., Langevitz, P., & Shoenfeld, Y. (2012) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-010-8243-x · Cited by 613
Chan, J. F.-W., Yao, Y., Yeung, M.-L., Deng, W., Bao, L., Jia, L., Li, F., Xiao, C., Gao, H., Yu, P., et al. (2015) · Journal of Infectious Diseases · doi:10.1093/infdis/jiv392 · Cited by 608
Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing
Mohler, K. M., Sleath, P. R., Fitzner, J. N., Cerretti, D. P., Alderson, M., Kerwar, S. S., Torranee, D. S., Otten-Evans, C., Greenstreet, T., Weerawarna, K., et al. (1994) · Nature · doi:10.1038/370218a0 · Cited by 588
Protease inhibitors targeting coronavirus and filovirus entry
Zhou, Y., Vedantham, P., Lu, K., Agudelo, J., Carrion, R., Nunneley, J. W., Barnard, D., Pöhlmann, S., McKerrow, J. H., Renslo, A. R., et al. (2015) · Antiviral Research · doi:10.1016/j.antiviral.2015.01.011 · Cited by 583
New insights into the antiviral effects of chloroquine
Savarino, A., Di Trani, L., Donatelli, I., Cauda, R., & Cassone, A. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70361-9 · Cited by 570
Severe Acute Respiratory Syndrome Coronavirus Viroporin 3a Activates the NLRP3 Inflammasome
Chen, I.-Y., Moriyama, M., Chang, M.-F., & Ichinohe, T. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00050 · Cited by 547
Emodin blocks the SARS coronavirus spike protein and angiotensin-converting enzyme 2 interaction
HO, T., WU, S., CHEN, J., LI, C., & HSIANG, C. (2007) · Antiviral Research · doi:10.1016/j.antiviral.2006.04.014 · Cited by 516
Kawase, M., Shirato, K., van der Hoek, L., Taguchi, F., & Matsuyama, S. (2012) · Journal of Virology · doi:10.1128/jvi.00094-12 · Cited by 515
GS-5734 and its parent nucleoside analog inhibit Filo-, Pneumo-, and Paramyxoviruses
Lo, M. K., Jordan, R., Arvey, A., Sudhamsu, J., Shrivastava-Ranjan, P., Hotard, A. L., Flint, M., McMullan, L. K., Siegel, D., Clarke, M. O., et al. (2017) · Scientific Reports · doi:10.1038/srep43395 · Cited by 513
Deng, L., Li, C., Zeng, Q., Liu, X., Li, X., Zhang, H., Hong, Z., & Xia, J. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.03.002 · Cited by 505
In Vitro and In Vivo Activities of Anti-Influenza Virus Compound T-705
Furuta, Y., Takahashi, K., Fukuda, Y., Kuno, M., Kamiyama, T., Kozaki, K., Nomura, N., Egawa, H., Minami, S., Watanabe, Y., et al. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.4.977-981.2002 · Cited by 501
Arbidol as a broad-spectrum antiviral: An update
Blaising, J., Polyak, S. J., & Pécheur, E.-I. (2014) · Antiviral Research · doi:10.1016/j.antiviral.2014.04.006 · Cited by 485
Sissoko, D., Laouenan, C., Folkesson, E., M’Lebing, A.-B., Beavogui, A.-H., Baize, S., Camara, A.-M., Maes, P., Shepherd, S., Danel, C., et al. (2016) · PLOS Medicine · doi:10.1371/journal.pmed.1001967 · Cited by 478
T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infections
Furuta, Y., Takahashi, K., Shiraki, K., Sakamoto, K., Smee, D. F., Barnard, D. L., Gowen, B. B., Julander, J. G., & Morrey, J. D. (2009) · Antiviral Research · doi:10.1016/j.antiviral.2009.02.198 · Cited by 471
ABT-378, a Highly Potent Inhibitor of the Human Immunodeficiency Virus Protease
Sham, H. L., Kempf, D. J., Molla, A., Marsh, K. C., Kumar, G. N., Chen, C.-M., Kati, W., Stewart, K., Lal, R., Hsu, A., et al. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.12.3218 · Cited by 471
Global patterns in coronavirus diversity
Anthony, S. J., Johnson, C. K., Greig, D. J., Kramer, S., Che, X., Wells, H., Hicks, A. L., Joly, D. O., Wolfe, N. D., Daszak, P., et al. (2017) · Virus Evolution · doi:10.1093/ve/vex012 · Cited by 427
Bertram, S., Heurich, A., Lavender, H., Gierer, S., Danisch, S., Perin, P., Lucas, J. M., Nelson, P. S., Pöhlmann, S., & Soilleux, E. J. (2012) · PLoS ONE · doi:10.1371/journal.pone.0035876 · Cited by 398
Chan, K. W., Wong, V. T., & Tang, S. C. W. (2020) · The American Journal of Chinese Medicine · doi:10.1142/s0192415x20500378 · Cited by 398
Favipiravir as a potential countermeasure against neglected and emerging RNA viruses
Delang, L., Abdelnabi, R., & Neyts, J. (2018) · Antiviral Research · doi:10.1016/j.antiviral.2018.03.003 · Cited by 388
Al-Bari, M. A. A. (2017) · Pharmacology Research & Perspectives · doi:10.1002/prp2.293 · Cited by 382
Effective inhibition of MERS-CoV infection by resveratrol
Lin, S.-C., Ho, C.-T., Chuo, W.-H., Li, S., Wang, T. T., & Lin, C.-C. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2253-8 · Cited by 358
Yan, Y., Zou, Z., Sun, Y., Li, X., Xu, K.-F., Wei, Y., Jin, N., & Jiang, C. (2013) · Cell Research · doi:10.1038/cr.2012.165 · Cited by 353
Yamamoto, M., Matsuyama, S., Li, X., Takeda, M., Kawaguchi, Y., Inoue, J.-I., & Matsuda, Z. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01043-16 · Cited by 340
Fan, H.-H., Wang, L.-Q., Liu, W.-L., An, X.-P., Liu, Z.-D., He, X.-Q., Song, L.-H., & Tong, Y.-G. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000797 · Cited by 304
Leneva, I. A., Russell, R. J., Boriskin, Y. S., & Hay, A. J. (2009) · Antiviral Research · doi:10.1016/j.antiviral.2008.10.009 · Cited by 297
Baicalin, a metabolite of baicalein with antiviral activity against dengue virus
Moghaddam, E., Teoh, B.-T., Sam, S.-S., Lani, R., Hassandarvish, P., Chik, Z., Yueh, A., Abubakar, S., & Zandi, K. (2014) · Scientific Reports · doi:10.1038/srep05452 · Cited by 278
Jin, Z., Smith, L. K., Rajwanshi, V. K., Kim, B., & Deval, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068347 · Cited by 268
Use of antiviral drugs to reduce COVID-19 transmission
Mitjà, O., & Clotet, B. (2020) · The Lancet Global Health · doi:10.1016/s2214-109x(20)30114-5 · Cited by 230
Novel Peptide Inhibitors of Angiotensin-converting Enzyme 2
Huang, L., Sexton, D. J., Skogerson, K., Devlin, M., Smith, R., Sanyal, I., Parry, T., Kent, R., Enright, J., Wu, Q.-L., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212934200 · Cited by 215
Han, D. P., Penn-Nicholson, A., & Cho, M. W. (2006) · Virology · doi:10.1016/j.virol.2006.01.029 · Cited by 214
Cepharanthine: An update of its mode of action, pharmacological properties and medical applications
Bailly, C. (2019) · Phytomedicine · doi:10.1016/j.phymed.2019.152956 · Cited by 204
Structure-Based Discovery of a Novel Angiotensin-Converting Enzyme 2 Inhibitor
Huentelman, M. J., Zubcevic, J., Hernández Prada, J. A., Xiao, X., Dimitrov, D. S., Raizada, M. K., & Ostrov, D. A. (2004) · Hypertension · doi:10.1161/01.hyp.0000146120.29648.36 · Cited by 188
Genetic evolution analysis of 2019 novel coronavirus and coronavirus from other species
Li, C., Yang, Y., & Ren, L. (2020) · Infection, Genetics and Evolution · doi:10.1016/j.meegid.2020.104285 · Cited by 182
Anti-malarial drug, artemisinin and its derivatives for the treatment of respiratory diseases
Cheong, D. H. J., Tan, D. W. S., Wong, F. W. S., & Tran, T. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.104901 · Cited by 177
Turner, A. J., Tipnis, S. R., Guy, J. L., Rice, G. I., & Hooper, N. M. (2002) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y02-021 · Cited by 169
WHO launches global megatrial of the four most promising coronavirus treatments
(2021) · AAAS Articles DO Group · doi:10.1126/science.abb8497 · Cited by 167
Ji, W., Huh, K., Kang, M., Hong, J., Bae, G. H., Lee, R., Na, Y., Choi, H., Gong, S. Y., Choi, Y.-H., et al. (2020) · Journal of Korean Medical Science · doi:10.3346/jkms.2020.35.e237 · Cited by 167
The Synthetic Antiviral Drug Arbidol Inhibits Globally Prevalent Pathogenic Viruses
Pécheur, E., Borisevich, V., Halfmann, P., Morrey, J. D., Smee, D. F., Prichard, M. N., Mire, C. E., Kawaoka, Y., Geisbert, T. W., & Polyak, S. J. (2016) · Journal of Virology · doi:10.1128/jvi.02077-15 · Cited by 159
Clinical trial analysis of 2019‐nCoV therapy registered in China
Zhang, Q., Wang, Y., Qi, C., Shen, L., & Li, J. (2020) · Journal of Medical Virology · doi:10.1002/jmv.25733 · Cited by 156
Sun, Y., Zhao, Y., Yao, J., Zhao, L., Wu, Z., Wang, Y., Pan, D., Miao, H., Guo, Q., & Lu, N. (2015) · Biochemical Pharmacology · doi:10.1016/j.bcp.2015.02.002 · Cited by 152
and the Saudi Critical Care Trials group, Arabi, Y. M., Asiri, A. Y., Assiri, A. M., Jokhdar, H., Alothman, A. F., Balkhy, H. H., AlJohani, S. M., Harbi, S. A. A., Kojan, S. M., et al. (2020) · Trials · doi:10.1186/s13063-019-3846-x · Cited by 142
Haga, S., Nagata, N., Okamura, T., Yamamoto, N., Sata, T., Yamamoto, N., Sasazuki, T., & Ishizaka, Y. (2009) · Antiviral Research · doi:10.1016/j.antiviral.2009.12.001 · Cited by 130
Guy, J. L., Jackson, R. M., Jensen, H. A., Hooper, N. M., & Turner, A. J. (2005) · FEBS Journal · doi:10.1111/j.1742-4658.2005.04756.x · Cited by 129
Arbidol and Other Low-Molecular-Weight Drugs That Inhibit Lassa and Ebola Viruses
Hulseberg, C. E., Fénéant, L., Wijs, K. S.-D., Kessler, N., Nelson, E. A., Shoemaker, C. J., Schmaljohn, C. S., Polyak, S. J., & White, J. M. (2019) · Journal of Virology · doi:10.1128/jvi.02185-18 · Cited by 128
Iwaki, M., Ino, Y., MOTOYOSHI, A., Ozeki, M., Sato, T., Kurumi, M., & Aoyama, T. (1986) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.41.155 · Cited by 119
Antiviral Efficacy of Flavonoids against Enterovirus 71 Infection in Vitro and in Newborn Mice
Dai, W., Bi, J., Li, F., Wang, S., Huang, X., Meng, X., Sun, B., Wang, D., Kong, W., Jiang, C., et al. (2019) · Viruses · doi:10.3390/v11070625 · Cited by 114
Murine Recombinant Angiotensin-Converting Enzyme 2
Ye, M., Wysocki, J. A., González‐Pacheco, F. R., Salem, M., Evora, K., Garcia-Halpin, L., Poglitsch, M., Schuster, M., & BATLLE, D. C. (2012) · Hypertension · doi:10.1161/hypertensionaha.112.198622 · Cited by 108
Flavonoids interfere with NLRP3 inflammasome activation
Lim, H. A., Min, D. S., Park, H., & Kim, H. P. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.06.022 · Cited by 107
Zhang, B., Li, Z., Xu, W., Xiang, C.-H., & Ma, Y. (2018) · PubMed Central · Cited by 101
Corbett, A., Lim, M. L., & Kashuba, A. D. M. (2002) · Annals of Pharmacotherapy · doi:10.1345/aph.1a363 · Cited by 100
Yamaya, M., Shimotai, Y., Hatachi, Y., Nadine, L., Tando, Y., Kitajima, Y., Matsuo, K., Kubo, H., Nagatomi, R., Hongō, S., et al. (2015) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2015.07.001 · Cited by 97
Choe, J., & Kim, S. (2017) · Inflammation · doi:10.1007/s10753-017-0542-4 · Cited by 79
Biosensors for Managing the COVID-19 Cytokine Storm: Challenges Ahead
Russell, S. M., Alba-Patiño, A., Barón, E., Borges-Sa, M., González‐Freire, M., & de la Rica, R. (2020) · ACS Sensors · doi:10.1021/acssensors.0c00979 · Cited by 76
Chen, H., Lin, H. P., Xie, S., Huang, B., Qian, Y., Chen, K., Niu, Y., Shen, H., Cai, J., Li, P., et al. (2018) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2018.12.019 · Cited by 75
Pedersen, K. B., Sriramula, S., Chhabra, K. H., Xia, H., & Lazartigues, E. D. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00339.2011 · Cited by 73
Mefloquine for preventing malaria during travel to endemic areas
Tickell‐Painter, M., Maayan, N., Saunders, R., Pace, C., & Sinclair, D. (2017) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006491.pub4 · Cited by 73
Trask, A. J., Groban, L., Westwood, B. M., Varagić, J., Ganten, D., Gallagher, P. E., Chappell, M. C., & Ferrario, C. M. (2010) · American Journal of Hypertension · doi:10.1038/ajh.2010.51 · Cited by 69
Development of Potent and Selective Phosphinic Peptide Inhibitors of Angiotensin-Converting Enzyme 2
Mores, A., Matziari, M., Beau, F., Cuniasse, P., Yiotakis, A., & Dive, V. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701275z · Cited by 67
Fu, S., Xu, L., Li, S., Qiu, Y., Liu, Y., Wu, Z., Ye, C., Hou, Y., & Hu, C. A. (2016) · Veterinary Research · doi:10.1186/s13567-016-0359-4 · Cited by 67
Nicotianamine is a novel angiotensin-converting enzyme 2 inhibitor in soybean
Takahashi, S., Yoshiya, T., Yoshizawa‐Kumagaye, K., & Sugiyama, T. (2015) · Biomedical Research · doi:10.2220/biomedres.36.219 · Cited by 62
on behalf of the TACTIC Investigative Team, Ramsey, M. L., Nuttall, J., & Hart, P. A. (2019) · Trials · doi:10.1186/s13063-019-3606-y · Cited by 57
Yamagata, K., Hashiguchi, K., Yamamoto, H., & Tagami, M. (2019) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0000000000000747 · Cited by 57
Hirota, M., Shimosegawa, T., Kitamura, K., Takeda, K., Takeyama, Y., Mayumi, T., Ito, T., Takenaka, M., Iwasaki, E., Sawano, H., et al. (2019) · Journal of Gastroenterology · doi:10.1007/s00535-019-01644-z · Cited by 52
Sai, J. K., Suyama, M., Kubokawa, Y., Matsumura, Y., Inami, K., & Watanabe, S. (2009) · Journal of Gastroenterology · doi:10.1007/s00535-009-0148-1 · Cited by 41
Medication for COVID-19—an Overview of Approaches Currently Under Study
Stahlmann, R., & Lode, H. M. (2020) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2020.0213 · Cited by 41
Preclinical evaluation of avermectins as novel therapeutic agents for alcohol use disorders
Khoja, S., Huynh, N., Warnecke, A. M. P., Asatryan, L., Jakowec, M. W., & Davies, D. L. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4869-9 · Cited by 25
East meets West in COVID-19 therapeutics
Wang, S., Zeng, X. L., Wang, Y., Zhao, Y., Chen, W., & Chen, Y. (2020) · Pharmacological Research · doi:10.1016/j.phrs.2020.105008 · Cited by 6
Cited by
Immune response in COVID-19: A review
Chowdhury, M. A., Hossain, N., Kashem, M. A., Shahid, M. A., & Alam, A. (2020) · Journal of Infection and Public Health · doi:10.1016/j.jiph.2020.07.001 · Cited by 445
Cytokine storm and COVID-19: a chronicle of pro-inflammatory cytokines
Fara, A., Mitrev, Z., Rosalia, R. A., & Assas, B. M. (2020) · Open Biology · doi:10.1098/rsob.200160 · Cited by 369
COVID-19, Mast Cells, Cytokine Storm, Psychological Stress, and Neuroinflammation
Kempuraj, D., Selvakumar, G. P., Ahmed, M. E., Raikwar, S. P., Thangavel, R., Khan, A., Zaheer, S. A., Iyer, S. S., Burton, C., James, D., et al. (2020) · The Neuroscientist · doi:10.1177/1073858420941476 · Cited by 289
Di Pierro, F., Derosa, G., Maffioli, P., Bertuccioli, A., Togni, S., Riva, A., Allegrini, P., Khan, A., Khan, S., Khan, B. A., et al. (2021) · International Journal of General Medicine · doi:10.2147/ijgm.s318720 · Cited by 182
A systematic review on AI/ML approaches against COVID-19 outbreak
Dogan, O., Tiwari, S., Jabbar, M. A., & Guggari, S. (2021) · Complex & Intelligent Systems · doi:10.1007/s40747-021-00424-8 · Cited by 87
Metadata
- Authors
- McKee, D. L., Sternberg, A., Stange, U., Laufer, S., & Naujokat, C.
- Venue
- Pharmacological Research
- Publisher
- Elsevier BV
- Published
- 2020-07
- Volume
- 157
- Pages
- 104859
- ISSN
- 1043-6618 (ISSN-L)
- OpenAlex
- W3021640348
- Cited by
- 562
- References
- 111
- FWCI
- 16.15
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.